Mr. C.K. Cheung reports

EVITRADE SUPPORTS CANADIAN SENATE VOTE ON MARIJUANA LEGALIZATION

Evitrade Health Systems Corp. welcomes and supports the Canadian Senate and its approval of Bill C-45 for the pending legalization of recreational marijuana laws for the country.

"The company is pleased over the support that the Canadian Senate has shown for the direction of the cannabis laws for the country," said chief executive officer C.K. Cheung. "As the company moves ahead with its development of technology and biomedical systems that improve the human condition, we see a unique fit with some of our technology and its use in the medical and recreational cannabis industries."

The company recently announced a letter of intent with Cantech Molecular Research Inc., whose focus is on the development of haploid breeding protocols for plants that will enable the delivery of consistent and predictable biologics at each and every growth cycle. "Utilizing Cantech's technology in scientific breeding of plants in the medical and recreational cannabis space is a true win for the sector and a needed support for patient comfort and product reliability," continued Mr. Cheung.

Management continues to strive to seek optimal business and commercialization strategies for the company, including the recent acquisition of Artillery Labs and other opportunities currently being pursued. This, with the continued relationship with Haywood Securities as financial adviser, has the company planning forward for a bright future.

About Evitrade Health Systems Corp.

Evitrade (formerly Auxellence Health Corp.) was founded in 2013 to provide on-line digital health care services for resolving common health problems. The current markets are weight management, high blood pressure, high blood glucose and heart arrhythmia.

We seek Safe Harbor.